Michael A. Metzger - Sep 30, 2022 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Sep 30, 2022
Transactions value $
-$548,736
Form type
4
Date filed
10/4/2022, 05:49 PM
Previous filing
Jul 27, 2022
Next filing
Oct 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $260K +29.6K +167.65% $8.77 47.3K Sep 30, 2022 Direct
transaction SNDX Common Stock Sale -$741K -29.6K -62.64% $25.02 17.7K Sep 30, 2022 Direct F1, F2
transaction SNDX Common Stock Options Exercise $25.3K +2.88K +16.33% $8.77 20.5K Oct 3, 2022 Direct
transaction SNDX Common Stock Sale -$72.1K -2.88K -14.03% $25.01 17.7K Oct 3, 2022 Direct F1, F3
transaction SNDX Common Stock Options Exercise $11.2K +1.28K +7.25% $8.77 18.9K Oct 4, 2022 Direct
transaction SNDX Common Stock Sale -$32K -1.28K -6.76% $25.02 17.7K Oct 4, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -29.6K -100% $0.00* 0 Sep 30, 2022 Common Stock 29.6K $8.77 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -2.88K -100% $0.00* 0 Oct 3, 2022 Common Stock 2.88K $8.77 Direct F4
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -1.28K -100% $0.00* 0 Oct 4, 2022 Common Stock 1.28K $8.77 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 690,759 options to purchase shares of common stock that are vested and immediately exercisable and a total of 485,001 options to purchase shares of common stock that have not yet vested.
F2 The sale prices ranged from $25.00 to $25.15.
F3 The sale prices ranged from $25.00 to $25.03.
F4 This option is fully vested.